Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Lung Cancer

Free Subscription Articles published in Mol Cancer Ther Retrieve available abstracts of 26 articles: HTML format Text format

Single Articles

January 2012
1. WANGPAICHITR M , Theodoropoulos G, Wu C, You M, et al
   The Relationship of Thioredoxin-1 and Cisplatin Resistance: Its Impact on ROS and Oxidative Metabolism in Lung Cancer Cells.
   Mol Cancer Ther. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. WILSON PM , Labonte MJ, Lenz HJ, Mack PC, et al
   Inhibition of dUTPase induces synthetic lethality with thymidylate synthase-targeted therapies in non-small cell lung cancer.
   Mol Cancer Ther. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. OKAMOTO K , Okamoto I, Hatashita E, Kuwata K, et al
   Overcoming erlotinib resistance in {not}EGFR mutation-positive non-small cell lung cancer cells by targeting survivin.
   Mol Cancer Ther. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. LIU Y , Sun SY, Owonikoko TK, Sica G, et al
   Rapamycin Induces Bad Phosphorylation in Association with Its Resistance to Human Lung Cancer Cells.
   Mol Cancer Ther. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. LIN YW , Tsai MS, Weng SH, Chen HJ, et al
   Inhibition of p38 MAPK-dependent excision repair cross-complementing 1 expression decreases the DNA repair capacity to sensitize lung cancer cells to etoposide.
   Mol Cancer Ther. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. TOYOOKA S , Gazdar AF
   Methylation profiling of lung cancer: a decade of progress.
   Mol Cancer Ther. 2011;10:2020.
   PubMed     Text format     Related articles   
   
   
   
   July 2011
7. ZHANG C , Elkahloun AG, Liao H, Delaney S, et al
   Expression signatures of the lipid-based Akt inhibitors phosphatidylinositol ether lipid analogues in NSCLC cells.
   Mol Cancer Ther. 2011;10:1137-48.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
8. RAI K , Takigawa N, Ito S, Kashihara H, et al
   Liposomal Delivery of MicroRNA-7-Expressing Plasmid Overcomes Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells.
   Mol Cancer Ther. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
9. OGINO H , Hanibuchi M, Kakiuchi S, Trung VT, et al
   E7080, a Multiple Tyrosine Kinase Inhibitor, Suppresses Hematogenous Multiple Organ Metastases of Lung Cancer Cells with Non-mutated Epidermal Growth Factor Receptor.
   Mol Cancer Ther. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2011
10. RAINA D , Kosugi M, Ahmad R, Panchamoorthy G, et al
    DEPENDENCE ON THE MUC1-C ONCOPROTEIN IN NON-SMALL CELL LUNG CANCER CELLS WITH EGFR AND K-RAS MUTATIONS.
    Mol Cancer Ther. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
11. SUNAGA N , Shames DS, Girard L, Peyton M, et al
    Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy.
    Mol Cancer Ther. 2011;10:336-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
12. SHER YP , Liu SJ, Chang CM, Lien SP, et al
    Cancer-Targeted BikDD Gene Therapy Elicits Protective Anti-Tumor Immunity Against Lung Cancer.
    Mol Cancer Ther. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. GUPTA S , Koru-Sengul T, Arnold SM, Devi G, et al
    Low-dose fractionated radiation potentiate the effects of Cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells.
    Mol Cancer Ther. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. SONG L , Rawal B, Nemeth JA, Haura EB, et al
    IL6/JAK1 pathway inhibition downregulates STAT3 and inhibits tumor growth in lung cancer.
    Mol Cancer Ther. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. JANTSCHEFF P , Schlesinger M, Fritzsche J, Taylor LA, et al
    Lysophosphatidylcholine pretreatment reduces VLA-4 and P-Selectin-mediated b16.f10 melanoma cell adhesion in vitro and inhibits metastasis-like lung invasion in vivo.
    Mol Cancer Ther. 2011;10:186-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
16. REKA AK , Kurapati H, Narala VR, Bommer G, et al
    Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition.
    Mol Cancer Ther. 2010;9:3221-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
17. WANG Y , James M, Wen W, Lu Y, et al
    Chemopreventive effects of pioglitazone on chemically induced lung carcinogenesis in mice.
    Mol Cancer Ther. 2010;9:3074-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
18. ICHITE N , Chougule M, Patel AR, Jackson T, et al
    Inhalation Delivery of a Novel Diindolylmethane Derivative for the Treatment of Lung Cancer.
    Mol Cancer Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
19. OKAMOTO W , Okamoto I, Tanaka K, Hatashita E, et al
    TAK-701, a humanized monoclonal antibody to HGF, reverses gefitinib resistance induced by tumor-derived HGF in non-small cell lung cancer with an EGFR mutation.
    Mol Cancer Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. NAGJI AS , Cho SH, Liu Y, Lee JK, et al
    Multi-gene expression-based predictors for sensitivity to Vorinostat and Velcade in non-small cell lung cancer.
    Mol Cancer Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. LUSZCZEK W , Cheriyath V, Mekhail TM, Borden EC, et al
    Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression.
    Mol Cancer Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. SINGH A , Wu H, Zhang P, Happel C, et al
    Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
    Mol Cancer Ther. 2010;9:2365-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
23. HIRAI H , Sootome H, Nakatsuru Y, Miyama K, et al
    MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.
    Mol Cancer Ther. 2010;9:1956-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
24. WANG D , Precopio M, Lan T, Yu D, et al
    Antitumor activity and immune response induction of a dual agonist of Toll-like receptors 7 and 8.
    Mol Cancer Ther. 2010;9:1788-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
25. GAN PP , McCarroll JA, Po'uha ST, Kamath K, et al
    Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin.
    Mol Cancer Ther. 2010;9:1339-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. AKAR U , Ozpolat B, Mehta K, Lopez-Berestein G, et al
    Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model.
    Mol Cancer Ther. 2010;9:1180-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: